Pascal Rathelot

1.4k total citations
57 papers, 1.0k citations indexed

About

Pascal Rathelot is a scholar working on Organic Chemistry, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Pascal Rathelot has authored 57 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Organic Chemistry, 13 papers in Molecular Biology and 9 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Pascal Rathelot's work include Synthesis and Biological Evaluation (15 papers), Synthesis and biological activity (11 papers) and Microwave-Assisted Synthesis and Applications (9 papers). Pascal Rathelot is often cited by papers focused on Synthesis and Biological Evaluation (15 papers), Synthesis and biological activity (11 papers) and Microwave-Assisted Synthesis and Applications (9 papers). Pascal Rathelot collaborates with scholars based in France, Egypt and Australia. Pascal Rathelot's co-authors include Patrice Vanelle, Pierre Verhaeghe, Nadine Azas, Sébastien Hutter, Sylvain Rault, Michèle Laget, Anita Cohen, Hussein El‐Kashef, José Maldonado and Marc Montana and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Green Chemistry.

In The Last Decade

Pascal Rathelot

49 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pascal Rathelot France 17 760 200 164 95 91 57 1.0k
Ibrahim M. El‐Deeb Australia 17 242 0.3× 258 1.3× 101 0.6× 124 1.3× 90 1.0× 38 712
Xinyong Liu China 15 210 0.3× 284 1.4× 74 0.5× 95 1.0× 79 0.9× 33 784
Vinita Chaturvedi India 25 911 1.2× 429 2.1× 45 0.3× 220 2.3× 48 0.5× 68 1.5k
Sharon A. Creason United States 12 295 0.4× 275 1.4× 118 0.7× 146 1.5× 47 0.5× 19 733
Mônica M. Bastos Brazil 15 595 0.8× 210 1.1× 120 0.7× 115 1.2× 43 0.5× 48 828
Huy Ngo United States 17 289 0.4× 253 1.3× 24 0.1× 106 1.1× 93 1.0× 43 812
Mehrnoosh Hashemzadeh United States 15 368 0.5× 287 1.4× 32 0.2× 143 1.5× 34 0.4× 49 1.2k
Yong-Kang Zhang China 16 388 0.5× 353 1.8× 160 1.0× 182 1.9× 75 0.8× 27 924
Thomas Zöller Germany 22 361 0.5× 156 0.8× 427 2.6× 196 2.1× 89 1.0× 71 1.4k

Countries citing papers authored by Pascal Rathelot

Since Specialization
Citations

This map shows the geographic impact of Pascal Rathelot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pascal Rathelot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pascal Rathelot more than expected).

Fields of papers citing papers by Pascal Rathelot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pascal Rathelot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pascal Rathelot. The network helps show where Pascal Rathelot may publish in the future.

Co-authorship network of co-authors of Pascal Rathelot

This figure shows the co-authorship network connecting the top 25 collaborators of Pascal Rathelot. A scholar is included among the top collaborators of Pascal Rathelot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pascal Rathelot. Pascal Rathelot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lamy, Edouard, et al.. (2025). Formulation, Quality Control and Stability Study of Pediatric Oral Dextrose Gel. Pharmaceuticals. 18(2). 204–204.
3.
Primas, Nicolas, Caroline Castera‐Ducros, Christophe Curti, et al.. (2024). 31st Annual GP2A Medicinal Chemistry Conference. SHILAP Revista de lepidopterología. 3(1). 209–243.
5.
Kieffer, Charline, Nicolas Primas, Sébastien Hutter, et al.. (2024). Target fishing reveals PfPYK-1 and PfRab6 as potential targets of an antiplasmodial 4-anilino-2-trichloromethylquinazoline hit compound. Bioorganic & Medicinal Chemistry. 102. 117654–117654.
6.
Primas, Nicolas, et al.. (2023). N-[1-(2-Chlorophenyl)-2-{1-methyl-5-nitro-4-[(phenylsulfonyl)methyl]-1H-imidazol-2-yl}ethyl]-4-methylbenzenesulfonamide. SHILAP Revista de lepidopterología. 2023(2). M1633–M1633.
7.
Primas, Nicolas, Sandra Bourgeade‐Delmas, Sébastien Hutter, et al.. (2022). Improving Aqueous Solubility and In Vitro Pharmacokinetic Properties of the 3-Nitroimidazo[1,2-a]pyridine Antileishmanial Pharmacophore. Pharmaceuticals. 15(8). 998–998. 3 indexed citations
8.
Curti, Christophe, et al.. (2020). Stockpiled N95 respirator/surgical mask release beyond manufacturer-designated shelf-life: a French experience. Journal of Hospital Infection. 106(2). 258–263. 3 indexed citations
9.
Desroches, Justine, Charline Kieffer, Nicolas Primas, et al.. (2016). Discovery of new hit-molecules targeting Plasmodium falciparum through a global SAR study of the 4-substituted-2-trichloromethylquinazoline antiplasmodial scaffold. European Journal of Medicinal Chemistry. 125. 68–86. 27 indexed citations
10.
Kieffer, Charline, Anita Cohen, Pierre Verhaeghe, et al.. (2015). Looking for new antileishmanial derivatives in 8-nitroquinolin-2(1H)-one series. European Journal of Medicinal Chemistry. 92. 282–294. 12 indexed citations
11.
Kieffer, Charline, Anita Cohen, Pierre Verhaeghe, et al.. (2015). Antileishmanial pharmacomodulation in 8-nitroquinolin-2(1H)-one series. Bioorganic & Medicinal Chemistry. 23(10). 2377–2386. 8 indexed citations
12.
Castera‐Ducros, Caroline, Lucie Paloque, Pierre Verhaeghe, et al.. (2013). Targeting the human parasite Leishmania donovani: Discovery of a new promising anti-infectious pharmacophore in 3-nitroimidazo[1,2-a]pyridine series. Bioorganic & Medicinal Chemistry. 21(22). 7155–7164. 31 indexed citations
13.
Paloque, Lucie, Pierre Verhaeghe, Magali Casanova, et al.. (2012). Discovery of a new antileishmanial hit in 8-nitroquinoline series. European Journal of Medicinal Chemistry. 54. 75–86. 48 indexed citations
14.
Cohen, Anita, Pierre Verhaeghe, Maxime D. Crozet, et al.. (2012). Tandem synthesis and in vitro antiplasmodial evaluation of new naphtho[2,1-d]thiazole derivatives. European Journal of Medicinal Chemistry. 55. 315–324. 35 indexed citations
15.
Montana, Marc, et al.. (2010). Safety Review: Squalene and Thimerosal in Vaccines. Therapies. 65(6). 533–541. 16 indexed citations
16.
Verhaeghe, Pierre, Nadine Azas, Sébastien Hutter, et al.. (2009). Synthesis and in vitro antiplasmodial evaluation of 4-anilino-2-trichloromethylquinazolines. Bioorganic & Medicinal Chemistry. 17(13). 4313–4322. 51 indexed citations
17.
Santos, Jana Sopková‐de Oliveira, Pierre Verhaeghe, Jean‐François Lohier, et al.. (2008). Nitrated isomers of 2-(trichloromethyl)quinoline. Acta Crystallographica Section C Crystal Structure Communications. 64(8). o441–o444.
18.
Verhaeghe, Pierre, Nadine Azas, M. Gasquet, et al.. (2007). Synthesis and antiplasmodial activity of new 4-aryl-2-trichloromethylquinazolines. Bioorganic & Medicinal Chemistry Letters. 18(1). 396–401. 142 indexed citations
19.
Vanelle, Patrice, Thierry Terme, Armand Gellis, & Pascal Rathelot. (2004). Les réactions de transfert monoélectronique : de l’électron au médicament. Annales Pharmaceutiques Françaises. 62(1). 20–28. 2 indexed citations
20.
Malissard, L, T.D. Nguyen, Geena Jung, et al.. (1991). Localized adenocarcinoma of the lung: A retrospective study of 186 non-metastatic patients from the french federation of cancer institutes—the radiotherapy cooperative group. International Journal of Radiation Oncology*Biology*Physics. 21(2). 369–373. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026